Back to Search
CHESLOVAS ROTHSCHILD, MD PHD FACS
MD PHD FACS
Neurological Surgery Physician
NPI: 1114919230IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
4301064527(MI)
CMS Specialties
PrimaryNEUROSURGERY
Education
OTHER
Class of 1983
Research & Publications (20)
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations.
PMID 19549989·Blood·2009
5-case
Characteristics, mechanisms of action, and epitope mapping of anti-factor VIII antibodies.
PMID 19172415·Clin Rev Allergy Immunol·2009
6-review
Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrate.
PMID 18627444·J Thromb Haemost·2008
8-other
Successful conservative treatment of traumatic subacute subdural haematomas in neonates with haemophilia A.
PMID 18034248·Childs Nerv Syst·2008
5-case
Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data.
PMID 17880432·Haemophilia·2007
4-observational
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients.
PMID 17403090·J Thromb Haemost·2007
3-trial
ReFacto and Advate: a single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia A.
PMID 17286764·Haemophilia·2007
4-observational
Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild/moderate hemophilia a and inhibitors.
PMID 16427382·Semin Hematol·2006
5-case
Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A.
PMID 16166584·Blood·2006
4-observational
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation.
PMID 15735795·Thromb Haemost·2005
3-trial
Recommendations for postmarketing surveillance studies in haemophilia and other bleeding disorders.
PMID 16011587·Haemophilia·2005
8-other
The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B.
PMID 15383463·Blood·2005
3-trial
Helcococcus ovis isolated from a pulmonary abscess in a horse.
PMID 15131196·J Clin Microbiol·2004
5-case
Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level.
PMID 15090828·AIDS·2004
8-other
Extracorporeal adsorption of anti-factor VIII allo-antibodies on randomly functionalized polystyrene resins.
PMID 14961152·Thromb Haemost·2004
8-other
Thermodynamic resolution of periosteal reaction and taphonomic change.
PMID 14513121·Reumatismo·2003
8-other
Unified theory of the origins of erosive arthritis: conditioning as a protective/directing mechanism?
PMID 14528501·J Rheumatol·2003
8-other
Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients.
PMID 14629482·J Thromb Haemost·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1887 KINGSLEY AVE, SUITE1900
ORANGE PARK, FL 32073 - Phone
- (904) 276-7336
Quick Facts
- NPI
- 1114919230
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile